Could a daily synbiotic soothe Alzheimer's behavior?

NCT ID NCT06948929

Recruiting now Symptom relief Sponsor: Chinese University of Hong Kong Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This pilot study is testing whether a daily synbiotic supplement called SCV09 can improve behavioral symptoms in people with Alzheimer's disease. The supplement contains probiotics, prebiotics, and vitamins thought to support the gut-brain connection. Thirty participants aged 60-85 with mild-to-moderate Alzheimer's will take the supplement for several weeks, and researchers will track changes in mood, behavior, and daily function.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SCV09 (a synbiotic formula with probiotics, prebiotics, and vitamins)
What this could lead to: If it works, this could point toward a simple dietary supplement to help manage behavioral symptoms in Alzheimer's disease.
What could go wrong: This is a very small, early pilot study with no placebo group, so results may not be reliable. The supplement may not improve symptoms at all.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALZHEIMER DISEASE

Contacts and locations

Locations

The Chinse University of Hong Kong
RECRUITING

Shatin, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.